Arrhythmia Alliance News & Events
Don't let cancelled/postponed conferences stop your educational learning! We have a large number of educational presentations available online HERE
ACC and AHA update performance measures for people with atrial fibrillation
In an update to the American College of Cardiology (ACC)/American Heart Association (AHA) Clinical Performance and Quality Measures on Atrial Fibrillation (AF) or Atrial Flutter, the writing committee for this 2020 document incorporated two changes to performance measures in accordance with the 2019 ACC/AHA/Heart Rhythm Society atrial fibrillation guideline focused update.
According to a press release, the first change in the document, which is incorporated into all the performance measures, is the definition of valvular AF, including for patients with either moderate or severe mitral stenosis or those with a mechanical prosthetic heart valve. The second change, which only applies to the performance measure of anticoagulation prescribed, is the different CHA2DS2-VASc risk score treatment thresholds for men (greater than one) and women (greater than two), further demonstrating that the risk of stroke differs for men and women with AF or atrial flutter. The press release states that successful implementation of these updated performance measures by clinicians and healthcare organisations will lead to quality improvement for adult patients with atrial fibrillation or atrial flutter.
The 2020 Update to the 2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter has been published online in the Journal of the American College of Cardiology and Circulation: Cardiovascular Quality and Outcomes. It was developed in collaboration with the Heart Rhythm Society.